Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2025-12-25 @ 5:19 PM
Study NCT ID:
NCT01115803
Status:
TERMINATED
Last Update Posted:
2019-02-05
First Post:
2010-04-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-22
First Submit QC Date:
None
Study First Post Date:
2010-05-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-27
Results First Submit QC Date:
None
Results First Post Date:
2019-01-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-17
Last Update Post Date:
2019-02-05
Last Update Post Date Type:
ACTUAL